DCAT Value Chain Insights

The EU and Fine Chemicals: What’s Next

The European Commission took another step to address ways to improve the resilience of the EU's pharmaceutical manufacturing value chain by issuing a revised roadmap for its Pharmaceutical Strategy...

FDA Issues New Guidance on Remote Inspections

Last week (April 14, 2021), the FDA issued final guidance on remote inspections, which the FDA has used in lieu of onsite inspections due to COVID-19 restrictions. The FDA is outlining what to...

SPONSORED CONTENT

A New Alliance: ICROM and PolyCrystalLine

Information
April 20, 2021
Sponsored by ICROM and PolyCrystalLine

ICROM and PolyCrystalLine SpA announce their strategic and exclusive partnership to provide integrated solutions for chemical development and custom manufacturing of APIs.

Read More
Build or Buy Challenge: Six Advantages of Using a Pre-Qualified, Fully Customizable GMP Environment

Information
March 17, 2021
Sponsored by Almac

Today, biopharma companies face growing challenges when capacity is at a premium. Investment decisions must be made to ultimately determine the expansion of facilities, headcounts and technology...

Read More
Getting Your Biologic to Clinic Faster & More Efficiently

Information
March 10, 2021
Sponsored by Catalent

Executive Summary There are a range of benefits in using an integrated supplier to streamline biologic drug development starting in early phase through clinical and commercial stages. Partnering...

Read More